文献速递乳腺妇产影像技术与安全PET

18F-氟沙坦曲的开发:一种用于成像聚(ADP-核糖)聚合酶-1的PET放射性示踪剂

The Development of 18F Fluorthanatrace: A PET Radiotracer for Imaging Poly (ADP-Ribose) Polymerase-1.
PubMed 文献 · Radiol Imaging Cancer · 2022-01-01

本文描述了18F-FTT作为PARP-1 PET放射性示踪剂从设计、临床前评估到首次人体成像研究及初步验证的逐步开发过程,用于测量乳腺癌和卵巢癌患者的PARP-1表达水平,并讨论了向FDA提交探索性研究性新药申请及商业化策略。

要点

  • 18F-FTT是靶向PARP-1的PET放射性示踪剂,用于成像PARP-1表达。
  • 已在乳腺癌和卵巢癌患者中完成首次人体成像研究及初步验证。
  • 本文提供学术机构PET示踪剂临床转化的路线图。

核心结论

  • 18F-FTT从设计到首次人体研究及初步验证的逐步开发已完成,可作为测量乳腺癌和卵巢癌患者PARP-1表达水平的影像生物标志物。

研究设计与样本

  • 本文为综述,描述了18F-FTT从设计、临床前评估到首次人体成像研究及初步验证的开发过程。
  • 讨论了向美国食品药品监督管理局提交探索性研究性新药申请的制备与提交过程。
  • 强调了识别商业化策略以克服开展多中心临床试验所需主要财务障碍的必要性和未来计划。

诊断标准与关键数值

  • 18F-FTT作为影像生物标志物用于测量乳腺癌和卵巢癌患者的PARP-1表达水平,初步验证结果原文未报告具体数值。

临床应用与阅片要点

  • 本文旨在为科学家和临床医生提供在学术环境中开发的PET放射性示踪剂成功临床转化的路线图。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Fluorine 18 (18F) fluorthanatrace (18F-FTT) is a PET radiotracer for imaging poly (adenosine diphosphate-ribose) polymerase-1 (PARP-1), an important target for a class of drugs known as PARP inhibitors, or PARPi. This article describes the stepwise development of this radiotracer from its design and preclinical evaluation to the first-in-human imaging studies and the initial validation of 18F-FTT as an imaging-based biomarker for measuring PARP-1 expression levels in patients with breast and ovarian cancer. A detailed discussion on the preparation and submission of an exploratory investigational new drug application to the Food and Drug Administration is also provided. Additionally, this review highlights the need and future plans for identifying a commercialization strategy to overcome the major financial barriers that exist when conducting the multicenter clinical trials needed for approval in the new drug application process. The goal of this article is to provide a road map that scientists and clinicians can follow for the successful clinical translation of a PET radiotracer developed in an academic setting. Keywords: Molecular Imaging-Cancer, PET, Breast, Genital/Reproductive, Chemistry, Radiotracer Development, PARPi, 18F-FTT, Investigational New Drug © RSNA, 2022.

来源:Radiol Imaging Cancer,查看原文。版权归原作者所有。

引用

  1. Lee HS, Schwarz SW, Schubert EK, et al. The Development of 18F Fluorthanatrace: A PET Radiotracer for Imaging Poly (ADP-Ribose) Polymerase-1. Radiol Imaging Cancer. 2022. PMID: 35089089. doi:10.1148/rycan.210070

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。